As an example, AML patients with an NPM1 mutation and no WT1 mutation are stratified as favorable-risk individuals, whereas the concomitant presence of both mutations significantly affects prognosis, so such patients are categorized as adverse-risk individuals [88]. The gene discussed is NPM1; the disease is acute myeloid leukemia.